Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.
In 2001, the World Health Organization (WHO) published its new classification of tumors of hematopoietic and lymphoid tissues, including an entity named posttransplantation lymphoproliferative disorder (PTLD). Because oral PTLD is of clinical relevance to oral health providers, the importance of distinguishing between PTLD and nontransplantation related lymphoma is outlined, and the clinical implications of oral PTLD are discussed.
D017809:Fatal Outcome; D005882:Gingival Diseases / Q000473:pathology* / Q000628:therapy / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D004854:Herpesvirus 4, Human; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000473:pathology* / Q000628:therapy / Q000821:virology; D008297:Male; D008875:Middle Aged; D014944:World Health Organization